Author: ssir.org

When Eli Lilly snapped up Scorpion Therapeutics’ PI3Kα program earlier this year, the deal allowed Scorpion to spin out a new entity that would house its preclinical pipeline. | Antares may be forging ahead with Scorpion’s leadership team, but the company is adopting a different approach designed to account for the drastic transformation in both the biotech and macroeconomic environments.Read More

Read More

Mark Peluchette, president of Liberty Distributors, joined the AccuWeather Early show to describe how, in a matter of minutes, they “went from just a little trickle of water” to a “river of water that was probably 50 yards wide” during the recent flash flooding in Triadelphia, West Virginia.Read More

Read More